- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03746678
Patient-Centred Perioperative Mobile Application
Patient-Centered Perioperative Care Through Mobile Application: Patient Engagement Prospective Cohort Study in Elective Cesarean Delivery Patients
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The objective of this cohort study is to build the mobile application and evaluate its feasibility in providing patient education and reminders for self-monitoring for cesarean delivery patients. The investigators will measure the extent of patient engagement with our application through in-app usage data, as well as receive quantitative and qualitative feedback regarding feasibility. By understanding user behavior and needs through questionnaires and application usage data, the investigators could design more effective and tailored interventions for patients. Results of this study will help further development and implementation of an interdisciplinary mobile monitoring and communication platform for perioperative care.
This study is funded by the Dalhousie University Department of Anesthesia, Pain Management & Perioperative Medicine.
Studietype
Registrering (Forventet)
Kontakter og plasseringer
Studiesteder
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3K 6R8
- Rekruttering
- Women's and Obstetric Anesthesia, IWK Health Centre
-
Ta kontakt med:
- Janny X Ke, MD
-
Underetterforsker:
- Ronald B George, MD FRCPC
-
Underetterforsker:
- Lori Wozney, PhD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
Part 1 (screened by asking nurse)
- Patient scheduled for elective Cesarean delivery
- Age equal or greater than 18
- American Society of Anesthesiologists (ASA) Physical Status I-III (i.e. not in life-threatening situation)
Part 2 (screened in person)
- Possesses an iOS Smartphone with active data plan and access to WiFi, and self-reported use of it on a regular basis (at this stage in development, the mobile application prototype is only available on iOS)
- Self-reported proficiency with Smartphone and mobile applications
- Reported fluency in English
Exclusion Criteria:
Self-reported physical or psychiatric condition that may impair the ability to use the mobile application, answer questionnaires and surveys, and/or provide insights representative of the general population, such as blindness, under current influence of recreational drugs or alcohol.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
C-Care Mobile Application
|
C-care is a mobile application developed based on previous research at the IWK Health Centre.
It contains topics relevant to Cesarean delivery and the recovery process, which the patient could access at anytime.
Patient engagement with the application will be monitored anonymously for 30 days after delivery.
On days one to five after delivery, patients will receive a short self-monitoring questionnaire (approximately 1 minute).
At the end of two weeks (14 days), patients will complete an online survey regarding overall satisfaction, potential impact on care, usability and feasibility problems.
At any point during the study, patients can email us to report any problems with the application.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Median number of information topics viewed per participant
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
Median number of self-monitoring questionnaires completed per participant
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
Median number of total visits to the mobile application per participant
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
Satisfaction score (scale of 0 to 10, 10 being extremely satisfied, 0 being not satisfied)
Tidsramme: 2 to 3 weeks
|
Quantitative responses from survey
|
2 to 3 weeks
|
Percentage of participants who would recommend the C-Care App to other women undergoing Cesarean delivery
Tidsramme: 2 to 3 weeks
|
Quantitative responses from survey
|
2 to 3 weeks
|
Percentage of self-monitoring questionnaires completed (out of 5) per participant
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Which topics were viewed the most (rank by topic name and by postoperative day)
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
Which self-monitoring questionnaires were filled the most (rank by postoperative day number)
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
Incidence of important potential anesthetic-related problems entered by the patient (pain, headache, weakness and numbness)
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
Time of the day patient visited site (scatter plot of Nova Scotia time vs. # visits) - one visit = at least one interaction within app, e.g. opening a topic, navigating within app
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
Time of the day patient filled out the questionnaire
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
Number of visits vs. postoperative day
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
Median duration (number of days starting from delivery date until the last day of visit) patient interacted with application.
Tidsramme: 30 days
|
Quantitative mobile application usage data
|
30 days
|
% participant who responded "yes" to the question that C-Care App provided them with knowledge about Cesarean delivery and anesthesia
Tidsramme: 2 to 3 weeks
|
Quantitative responses from survey
|
2 to 3 weeks
|
% participant who responded "yes" to the question that C-Care App provided them with knowledge about potential complications to monitor for
Tidsramme: 2 to 3 weeks
|
Quantitative responses from survey
|
2 to 3 weeks
|
% participant who responded "yes" to the question that C-Care App provided them with knowledge about the recovery process after Cesarean delivery
Tidsramme: 2 to 3 weeks
|
Quantitative responses from survey
|
2 to 3 weeks
|
Anything the patient wanted to change about this application, in terms of content, navigation, appearance, and overall experience?
Tidsramme: 2 to 3 weeks
|
Qualitative responses from survey
|
2 to 3 weeks
|
If the patient did not use the mobile application, what were the reasons?
Tidsramme: 2 to 3 weeks
|
Qualitative responses from survey
|
2 to 3 weeks
|
How could we make the mobile application more helpful for the patient?
Tidsramme: 2 to 3 weeks
|
Qualitative responses from survey
|
2 to 3 weeks
|
What do patients think about the name of this App, "C-Care"? Do they have any other suggestions for our name/logo?
Tidsramme: 2 to 3 weeks
|
Qualitative responses from survey
|
2 to 3 weeks
|
Any other comments and/or suggestions
Tidsramme: 2 to 3 weeks
|
Qualitative responses from survey
|
2 to 3 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Forventet)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- IWK1023201
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Levering med keisersnitt
-
G. d'Annunzio UniversityFullførtTwin Vaginal Delivery SkillsItalia
-
Duke UniversityUniversity of Colorado, Denver; Northwestern University; University of California... og andre samarbeidspartnereFullførtGjennomførbarhet av Best Supportive Care Delivery
-
Postgraduate Institute of Medical Education and...FullførtAnestesi | Closed Loop Anesthesia Delivery System (CLADS)India
Kliniske studier på C-Care Mobile Application
-
National University Hospital, SingaporeFullførtPeriodontitt | Gingivitt | Plakett, tannlegeSingapore
-
Pakistan Institute of Living and LearningHar ikke rekruttert ennåUtforskende randomisert kontrollert utprøving av en kunstig intelligens-selvskadeapplikasjon (AISHA)Selvmord | SelvskadingPakistan
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityFullførtRefraktært diffust stort B-celle lymfomKina
-
University of Massachusetts, WorcesterJohns Hopkins University; National Institute of Nursing Research (NINR); National... og andre samarbeidspartnereRekrutteringTraumatisk hjerneskade | Akutt iskemisk hjerneslag | Hemorragisk hjerneslag, intracerebraltForente stater
-
Shanghai Tongji Hospital, Tongji University School...Cellular Biomedicine Group Ltd.Fullført
-
The Second Hospital of Nanjing Medical UniversityUkjentPrimært hepatocellulært karsinom
-
RenJi HospitalAbelZeta Pharma Inc.RekrutteringSystemisk lupus erythematosus (SLE) | Nevromyelitt Optica Spectrum Disorders | Immun-mediert nekrotiserende myopati | Multippel sklerose-Relapsing-RemittingKina
-
Wenbin QianZhejiang Provincial Tongde HospitalUkjent
-
Assiut UniversityHar ikke rekruttert ennåJuvenil idiopatisk artritt
-
Peking Union Medical College HospitalCellular Biomedicine Group Ltd.FullførtB-celle non-Hodgkin lymfomKina